Latest Inflammatory breast cancer Stories
Researchers recently found that there are more advantages than disadvantages related to breast screening mammograms for women in their 40s who have a higher risk of having breast cancer.
Inflammatory breast cancer (IBC) is a very aggressive, often misunderstood type of cancer that is diagnosed more frequently in younger women compared with other types of breast cancer.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that women with breast pain who receive imaging (mammograms, MRIs or ultrasounds) as part of breast pain evaluation, undergo follow-up diagnostic testing, but do not gain benefit from these additional studies.
Every day 18 Swedish women are diagnosed with breast cancer.
It kills wives, daughters, moms, and friends. One out of every 36 women die of breast cancer. Among postmenopausal women with hormone receptor-positive breast cancer, their risk of dying from breast cancer increases with age.
The presence of circulating tumor cells in the blood appears to have no relationship to survival in women who have just been diagnosed with inflammatory breast cancer.
The American Society of Breast Surgeons suggests that the evidence in the MD Anderson study should be considered in pre-surgical counseling but is not strong enough to preclude the use of APBI
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight.
A second, larger clinical research study led by breast cancer specialists at Princess Margaret Hospital (PMH) has again proven that comparing a new biopsy of progressing or recurring cancer with that of the original cancer can dictate a change in treatment.
Amplification of anaplastic lymphoma kinase, which has been reported in other cancers such as non-small cell lung cancers, may be a primary driver of the rapid metastasis that patients with inflammatory breast cancer experience.
- A political dynamiter.